Finance

Lists
AMRUTANJAN:NSE
Amrutanjan Health Care Ltd
₹502.00
-1.05%
(-5.35) 1D
Sep 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AMRUTANJAN...
Open
₹509.00
High
₹516.00
Low
₹500.10
Mkt. cap
14.61B
Avg. vol.
0.00
Volume
41.07K
Dividend
0.98%
Quarterly dividend
₹1.22
Ex-dividend date
Sep 11, 2026
P/E ratio
26.88
52-wk high
₹790.95
52-wk low
₹482.80
EPS
₹18.67
Shares outstanding
29.23M
No. of employees
661
Open
₹509.00
High
₹516.00
Low
₹500.10
Mkt. cap
14.61B
Avg. vol.
0.00
Volume
41.07K
Dividend
0.98%
Quarterly dividend
₹1.22
Ex-dividend date
Sep 11, 2026
P/E ratio
26.88
52-wk high
₹790.95
52-wk low
₹482.80
EPS
₹18.67
Shares outstanding
29.23M
No. of employees
661
Profile
Amrutanjan Healthcare Limited is an Indian pharmaceutical company headquartered in Chennai, Tamil Nadu, India. It was founded by Kasinadhuni Nageswara Rao in Bombay in 1893. Wikipedia
About Amrutanjan Health Care Ltd
CEO-
Employees661
Founded1893
HeadquartersChennai, Tamil Nadu, India
SectorPharmaceutical industry
Websiteamrutanjan.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.18B
1.41B
1.50B
1.03B
Cost of goods sold
576.55M
637.94M
789.58M
542.79M
Cost of revenue
576.55M
637.94M
789.58M
542.79M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
297.00M
374.89M
-186.16M
274.66M
Operating expense
450.77M
537.01M
534.06M
463.91M
Total operating expenses
1.03B
1.17B
1.32B
1.01B
Operating income
149.68M
235.44M
176.08M
22.98M
Other non operating income
42.96M
41.20M
-126.45M
38.15M
EBT including unusual items
192.15M
263.64M
210.16M
60.69M
EBT excluding unusual items
192.15M
276.16M
208.37M
60.69M
Income tax expense
52.53M
69.12M
48.23M
17.04M
Effective tax rate
27.34%
26.22%
22.95%
28.07%
Other operating expenses
138.19M
145.88M
704.15M
170.10M
Net income
139.62M
194.52M
161.93M
43.66M
Net profit margin
11.86%
13.79%
10.80%
4.24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
159.20M
-
Interest expense
-497.00K
-479.00K
-459.00K
-439.00K
Net interest expenses
-497.00K
-479.00K
158.74M
-439.00K
Depreciation and amortization charges
15.58M
16.24M
16.06M
19.15M
EBITDA
165.12M
248.47M
189.24M
38.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps